Home > Press > Applied Nanoscience Issues Progress Report
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN) today issued the following progress report:
Applied Nanoscience Issues Progress Report
CARLSBAD, CA | Posted on March 6th, 2008
Testing of filter samples incorporating the company's proprietary silver nanoparticle formulation were tested after a simulated one-year aging process and proved to be highly effective in eradicating avian influenza. An independent BSL-3 laboratory reported a 3.6 log reduction (equivalent to a 99.96% reduction) in the avian influenza simulant H9N2 when exposed to the one-year aged nanoparticle enhanced filter media.
The technology, which has been under development for the past several years, has demonstrated effectiveness against a broad range of other pathogens, such as Staphylococcus aureus, Streptococcus pneumoniae, and the drug resistant S. aureus MRSA.
"We are very encouraged at the sustained progress made with our Nanoparticle - Enhanced - Filtration - Technology platform. The continued focus of our scientific team to include recent scale-up success has put us in a position to begin targeting license partners in a number of consumer markets," said Thomas Allen, President and CEO, ANI.
On February 8, 2008 Applied Nanoscience filed a Form 10-SB under Section 12(g) of The Securities Exchange Act of 1934 to become a fully reporting company. Filing this document one of the necessary steps the company must take to advance to the OTC Bulletin Board (OTCBB). An eventual listing on the OTCBB is expected to enhance the company's profile in public equity markets and make it easier to attract financing.
About Applied Nanoscience Inc.
Applied Nanoscience Inc. is a marketer and developer of innovative, high-performance filtration products, systems and technologies to customers worldwide in a focused effort to provide a safer tomorrow.
For more information, please click here
PAN Consultants Ltd.
Copyright © Marketwire
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
News and information
JPK announces expansion of its global sales and service activities in China and USA April 15th, 2014
Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014
PAM-XIAMEN Offers UV LED wafer April 15th, 2014
Engineers develop new materials for hydrogen storage April 15th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014
Graphene industry takes further step towards commercialisation with Haydale IPO listing March 19th, 2014
Tiny particles could help verify goods: Chemical engineers hope smartphone-readable microparticles could crack down on counterfeiting April 15th, 2014
A molecular approach to solar power: Switchable material could harness the power of the sun ó even when itís not shining April 15th, 2014
Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014
Biologists Develop Nanosensors to Visualize Movements and Distribution of Plant Stress Hormone April 15th, 2014